ID   CHO dhfr(-) Bcl2
AC   CVCL_JZ93
DR   Wikidata; Q54812577
RX   Patent=US20040014218;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Collection for Type Culture; KCTC 10142BP.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
RX   Patent=US20040014218;
RA   Lee, Gyun Min
RA   Lee, Suk Kyoo
RT   "DHFR-deficient CHO cell line transfected with an anti-apoptotic gene,
RT   method for preparation thereof, and method for producing target
RT   protein using the same.";
RL   Patent number US20040014218, 22-Jan-2004.
//